{"id":"https://openalex.org/W2921078326","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.509","title":"Meta-analysis of breast cancer expression data using published gene signatures to reveal key cellular processes implicated in chemosensitivity and resistance.","display_name":"Meta-analysis of breast cancer expression data using published gene signatures to reveal key cellular processes implicated in chemosensitivity and resistance.","publication_year":2015,"publication_date":"2015-05-20","ids":{"openalex":"https://openalex.org/W2921078326","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.509","mag":"2921078326"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2015.33.15_suppl.509","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.509","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2015.33.15_suppl.509","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049785882","display_name":"Daniel G. Stover","orcid":"https://orcid.org/0000-0001-9003-8165","observed_orcids":["https://orcid.org/0000-0001-9003-8165"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel G. Stover","raw_affiliation_strings":["Dana Farber Cancer Inst, Brookline, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Inst, Brookline, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043214812","display_name":"Laura M. Selfors","orcid":"https://orcid.org/0000-0002-1317-7353","observed_orcids":["https://orcid.org/0000-0002-1317-7353"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura M Selfors","raw_affiliation_strings":["Harvard Medical School, Department of Cell Biology, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Harvard Medical School, Department of Cell Biology, Boston, MA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026521984","display_name":"Jonathan L. Coloff","orcid":"https://orcid.org/0000-0003-4726-3097","observed_orcids":["https://orcid.org/0000-0003-4726-3097"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan L Coloff","raw_affiliation_strings":["Harvard Medical School, Department of Cell Biology, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Harvard Medical School, Department of Cell Biology, Boston, MA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043845770","display_name":"Joan S. Brugge","orcid":"https://orcid.org/0000-0002-2547-4814","observed_orcids":["https://orcid.org/0000-0002-2547-4814"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joan S Brugge","raw_affiliation_strings":["Harvard Medical School, Department of Cell Biology, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Harvard Medical School, Department of Cell Biology, Boston, MA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070245248","display_name":"Eric P. Winer","orcid":"https://orcid.org/0000-0002-8819-1723","observed_orcids":["https://orcid.org/0000-0002-8819-1723"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric P. Winer","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.02358783,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"33","issue":"15_suppl","first_page":"509","last_page":"509"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10885","display_name":"Gene expression and cancer classification","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9950000047683716},{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.8230000138282776},{"id":"https://openalex.org/keywords/chemosensitivity","display_name":"chemosensitivity","score":0.8740000128746033},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.9670000076293945},{"id":"https://openalex.org/keywords/pathological-complete-response","display_name":"pathological complete response","score":0.9200000166893005},{"id":"https://openalex.org/keywords/residual-disease","display_name":"residual disease","score":0.9509999752044678},{"id":"https://openalex.org/keywords/gene-expression-signatures","display_name":"gene expression signatures","score":0.9279999732971191},{"id":"https://openalex.org/keywords/proliferation-signature","display_name":"proliferation signature","score":0.7609999775886536},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.8119999766349792},{"id":"https://openalex.org/keywords/estrogen-receptor-positive-breast-cancer","display_name":"estrogen receptor-positive breast cancer","score":0.8870000243186951},{"id":"https://openalex.org/keywords/epithelial-mesenchymal-transition","display_name":"epithelial-mesenchymal transition","score":0.9449999928474426},{"id":"https://openalex.org/keywords/src-signaling","display_name":"Src signaling","score":0.8320000171661377},{"id":"https://openalex.org/keywords/tgf-beta-signaling","display_name":"TGF-beta signaling","score":0.9890000224113464},{"id":"https://openalex.org/keywords/lymph-node-status","display_name":"lymph node status","score":0.8059999942779541},{"id":"https://openalex.org/keywords/cell-of-origin","display_name":"cell of origin","score":0.37400001287460327}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6454167366027832},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.6032974720001221},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5965217351913452},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5933980345726013},{"id":"https://openalex.org/C2779733811","wikidata":"https://www.wikidata.org/wiki/Q5531562","display_name":"Gene signature","level":4,"score":0.5564772486686707},{"id":"https://openalex.org/C16930146","wikidata":"https://www.wikidata.org/wiki/Q4381253","display_name":"Stromal cell","level":2,"score":0.5512885451316833},{"id":"https://openalex.org/C18431079","wikidata":"https://www.wikidata.org/wiki/Q1502169","display_name":"Gene expression profiling","level":4,"score":0.4208940863609314},{"id":"https://openalex.org/C76419328","wikidata":"https://www.wikidata.org/wiki/Q74419","display_name":"Epithelial\u2013mesenchymal transition","level":4,"score":0.4158678352832794},{"id":"https://openalex.org/C162317418","wikidata":"https://www.wikidata.org/wiki/Q252857","display_name":"Transcriptome","level":4,"score":0.41395947337150574},{"id":"https://openalex.org/C8415881","wikidata":"https://www.wikidata.org/wiki/Q6839217","display_name":"Microarray analysis techniques","level":4,"score":0.4114692509174347},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4067420959472656},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.37754160165786743},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.28801220655441284},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.16666904091835022},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.12812340259552002}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2015.33.15_suppl.509","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.509","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2015.33.15_suppl.509","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2473583993","https://openalex.org/W2123089413","https://openalex.org/W2408455028","https://openalex.org/W2593961340","https://openalex.org/W2249747450","https://openalex.org/W2018535074","https://openalex.org/W2328043145","https://openalex.org/W2321520688","https://openalex.org/W2762981849","https://openalex.org/W3180750785"],"abstract_inverted_index":{"509":[0],"Background:":[1],"Although":[2],"many":[3],"pathways":[4],"and":[5,25,60,120,135,140,170,176,204,207,238,272],"cell":[6,57,82],"states":[7],"are":[8],"implicated":[9],"in":[10,93,108,160,258,274],"therapeutic":[11],"resistance,":[12],"predicting":[13],"response":[14,28,191],"to":[15,42,101,245],"chemotherapy":[16,190],"remains":[17],"a":[18,79,259],"challenge.":[19],"Methods:":[20],"We":[21],"assembled":[22],"expression":[23,261],"data":[24,77,123,262],"pathologic":[26],"complete":[27],"(pCR)":[29],"versus":[30,112,230],"residual":[31],"disease":[32],"(RD)":[33],"status":[34],"for":[35,124,155],"1,507":[36],"breast":[37,80,133,167,275],"cancer":[38,134],"samples":[39],"collected":[40],"prior":[41],"neoadjuvant":[43],"chemotherapy.":[44],"For":[45,185],"each":[46],"sample,":[47],"we":[48,103],"evaluated":[49,104],"118":[50],"published":[51],"gene":[52],"signatures":[53,90,187,257],"including":[54],"signaling,":[55],"lineage,":[56],"state,":[58],"immune,":[59],"microenvironmental":[61],"processes.":[62],"Results:":[63],"Among":[64,131],"all":[65],"signatures,":[66],"the":[67,158,171],"strongest":[68],"predictors":[69],"of":[70,144,157,178,233,243],"pCR":[71,111,247],"vs.":[72],"RD":[73,113],"were":[74,148,183],"proliferation-related.":[75],"Microarray":[76],"from":[78],"epithelial":[81],"morphogenesis":[83],"assay":[84],"demonstrated":[85],"that":[86,151],"five":[87,194],"separate":[88],"proliferation":[89,99,125,129,152],"correlated":[91],"with":[92,110,189,219,270],"vitro":[94],"proliferation.":[95],"To":[96],"assess":[97],"how":[98],"contributes":[100],"chemosensitivity,":[102],"genes":[105,147],"differentially":[106,145,179],"expressed":[107,146,180],"patients":[109],"(FDR-adjusted":[114],"p":[115],"<":[116],"0.05,":[117],"limma)":[118],"before":[119],"after":[121],"normalizing":[122],"using":[126],"two":[127],"distinct":[128],"signatures.":[130],"ER+":[132,136,161],"subsets":[137],"Luminal":[138],"A":[139],"B,":[141],">":[142],"95%":[143,251],"proliferation-associated,":[149],"suggesting":[150],"differences":[153],"account":[154],"most":[156],"variation":[159],"chemosensitivity.":[162],"In":[163],"comparison,":[164],"among":[165],"triple-negative":[166],"cancers":[168],"(TNBCs)":[169],"basal-like":[172],"subset,":[173],"only":[174],"72.0%":[175],"35.4%":[177],"genes,":[181],"respectively,":[182],"proliferation-associated.":[184],"TNBCs,":[186],"associated":[188,269],"clustered":[192],"into":[193,266],"key":[195,267],"areas:":[196],"proliferation,":[197],"mesenchymal":[198],"phenotype,":[199],"TGF-beta":[200],"signaling/stromal":[201],"features,":[202],"cyclin":[203],"Src":[205,239],"activation,":[206],"ER":[208],"signaling":[209],"(possibly":[210],"low-level":[211],"not":[212],"detected":[213],"by":[214,228],"IHC).":[215],"Stratifying":[216],"175":[217],"TNBCs":[218],"zero":[220],"(N0)":[221],"or":[222],"few":[223],"positive":[224],"lymph":[225],"nodes":[226],"(N1)":[227],"high":[229],"low":[231],"activity":[232],"three":[234],"signatures\u2014proliferation,":[235],"epithelial-to-mesenchymal":[236],"transition,":[237],"signaling\u2014was":[240],"highly":[241],"predictive":[242],"failure":[244],"achieve":[246],"(negative-predictive":[248],"value":[249],"0.965;":[250],"CI":[252],"0.912-0.990).":[253],"Conclusions:":[254],"Interrogating":[255],"multiple":[256],"large":[260],"set":[263],"allows":[264],"insights":[265],"processes":[268],"chemoresistance":[271],"sensitivity":[273],"cancer.":[276]},"counts_by_year":[],"updated_date":"2026-10-22T18:32:59.640997","created_date":"2019-03-22T00:00:00"}